CRENESSITY
Live / Registered — Registered (as of 20 Oct 2026)
What this means for you
Registered since 20 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 99975823
- Registration number
- 8518177
- Mark type
- Design + words
- Filed
- 29 Jan 2025
- Published for opposition
- 15 Jul 2025
- Registered
- 20 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 20 Oct 2032 (grace period to 20 Apr 2033)
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 042 — Scientific and technological services: Providing medical research information; conducting post authorization pharmaceutical research for the marketing of pharmaceutical preparations and evaluating epidemiological results
- Class 044 — Medical, beauty and agricultural services: Providing medical information; Providing medical information to insurance companies in the field of congenital adrenal hyperplasia; on-line information services, namely, providing medical information to insurance companies in the field of congenital adrenal hyperplasia
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 20 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 30 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Sept 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Sept 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Sept 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Sept 2026 — USE AMENDMENT FILED
- 16 Sept 2026 — DIVISIONAL PROCESSING COMPLETE
- 08 Sept 2026 — DIVISIONAL REQUEST RECEIVED
- 08 Sept 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 08 Sept 2026 — TEAS STATEMENT OF USE RECEIVED
- 21 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jul 2026 — CORRECTED NOA E-MAILED